AstraZeneca

Episode #71 What is WHO’s recommendation for COVID-19 vaccines for children? What does the evidence tell us about safety of these vaccines for children? If you live in a country…

In July 2021, Alexion was acquired by AstraZeneca, marking the creation of Alexion, AstraZeneca Rare Disease. Alexion and AstraZeneca share a dedication to science, to innovation, and to delivering life-changing…

At Alexion, AstraZeneca Rare Disease, we aim to build a team of passionate individuals committed to making a difference for rare disease patients and their families. Hear from a few…

As a rising force within AZ’s global business, our Global Hub in the vibrant city of Barcelona has quickly gathered momentum to become an important international center of excellence in…

Barbara is a lung cancer survivor. Her powerful story dispels misconceptions and stigma associated with lung cancer and gives a fresh perspective and realistic hope for patients now and in…

At AstraZeneca, postdoctoral researchers make valuable contributions to our R&D. As a postdoc, you get to lead an innovative 3-year project, are supported to learn new skills, have opportunities to…

In this segment of the Bioprocess Online Live event Bioprocess Intensification In The Real World, Irina Ramos, Ph.D., Director of Bioprocess Technology and Engineering at AstraZeneca, and AbbVie Principal Scientist…

Good health is what we all desire for ourselves and our loved ones but achieving something this significant for as many people as possible can’t be accomplished through a single…

At AstraZeneca, we are proud to partner with stakeholders across the healthcare ecosystem to help deliver more resilient, equitable healthcare. Find out more about why this is so critical in…

To mark Uterine Cancer Awareness Month (UCAM), now in its second year, we joined the International Gynecologic Cancer Society (IGCS) and their advocacy network, the International Gynecologic Cancer Advocacy Network…